Literature DB >> 28345456

Overexpression of miR-10b in colorectal cancer patients: Correlation with TWIST-1 and E-cadherin expression.

Rania Abdelmaksoud-Dammak1, Nour Chamtouri1, Mouna Triki1, Amena Saadallah-Kallel1, Wajdi Ayadi1, Slim Charfi2, Abdelmajid Khabir2, Lobna Ayadi2, Tahia Sallemi-Boudawara2, Raja Mokdad-Gargouri1.   

Abstract

MicroRNAs are emergent players of epigenetics that function as oncogenes or tumor suppressors and that have been implicated in regulating diverse cellular pathways. MiR-10b is an oncogenic microRNA involved in tumor invasion and metastasis in various cancers. Our data have shown that miR-10b is overexpressed in colorectal cancer samples in comparison with non-tumorous adjacent mucosa (p = 0.0025) and that it is associated with severe features such as tumor size >5 cm (p = 0.023), distant metastasis (p = 0.0022), non-differentiated tumors (p = 0.016), and vascular invasion (p = 0.01). Regarding the regulation of its expression, positive correlation between the loss of miR-10b and aberrant DNA methylation (p = 0.02) as well as a loss of TWIST-1 messenger RNA (p = 0.018) have been observed. Furthermore, expression analysis of the downstream miR-10b targets has shown that there are associations between low HOXD10 messenger RNA and E-cadherin protein levels (p < 0.0001, p = 0.0008, respectively) and overexpression of miR-10b. Our data suggests that overexpression of miR-10b results from high levels of TWIST-1 and may induce a decrease of E-cadherin membranous protein levels, thus contributing to the acquisition of metastatic phenotypes in colorectal cancer.

Entities:  

Keywords:  E-cadherin; HOXD10; MiR-10b; TWIST-1; methylation; regulation

Mesh:

Substances:

Year:  2017        PMID: 28345456     DOI: 10.1177/1010428317695916

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

Review 1.  The fundamental role of miR-10b in metastatic cancer.

Authors:  Patrick Sheedy; Zdravka Medarova
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

2.  Diversity and signature of small RNA in different bodily fluids using next generation sequencing.

Authors:  Mohamed El-Mogy; Bernard Lam; Taha A Haj-Ahmad; Shannon McGowan; Darrick Yu; Lucas Nosal; Nezar Rghei; Pam Roberts; Yousef Haj-Ahmad
Journal:  BMC Genomics       Date:  2018-05-29       Impact factor: 3.969

3.  Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin.

Authors:  Byunghee Yoo; Patricia Greninger; Giovanna T Stein; Regina K Egan; Joseph McClanaghan; Anna Moore; Cyril H Benes; Zdravka Medarova
Journal:  PLoS One       Date:  2018-07-20       Impact factor: 3.240

4.  Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.

Authors:  Tao Zhang; Jianrong Guo; Jian Gu; Zheng Wang; Guobin Wang; Huili Li; Jiliang Wang
Journal:  Oncol Rep       Date:  2018-11-01       Impact factor: 3.906

5.  Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1.

Authors:  Jun Li; Md Asaduzzaman Khan; Chunli Wei; Jingliang Cheng; Hanchun Chen; Lisha Yang; Iqra Ijaz; Junjiang Fu
Journal:  Molecules       Date:  2017-12-04       Impact factor: 4.411

6.  A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas.

Authors:  Monika Wimmer; Roland Zauner; Michael Ablinger; Josefina Piñón-Hofbauer; Christina Guttmann-Gruber; Manuela Reisenberger; Thomas Lettner; Norbert Niklas; Johannes Proell; Mila Sajinovic; Paul De Souza; Stefan Hainzl; Thomas Kocher; Eva M Murauer; Johann W Bauer; Dirk Strunk; Julia Reichelt; Albert Sleiman Mellick; Verena Wally
Journal:  Cell Commun Signal       Date:  2020-04-10       Impact factor: 5.712

Review 7.  Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma.

Authors:  Adriana G Quiroz-Reyes; Jose F Islas; Paulina Delgado-Gonzalez; Hector Franco-Villarreal; Elsa N Garza-Treviño
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

8.  Comprehensive evaluation of microRNA-10b in digestive system cancers reveals prognostic implication and signaling pathways associated with tumor progression.

Authors:  Yi Shen; Xiaolei Dai; Haibo Chen; Shuwei Zhai; Qiliang Peng; Shang Cai; Yaqun Zhu; Jian Huan; Yuntian Shen
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

9.  Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.

Authors:  Yu-Hong Yuan; Han-Yu Wang; Yu Lai; Wa Zhong; Wei-Ling Liang; Fu-de Yan; Zhong Yu; Jun-Kai Chen; Ying Lin
Journal:  Cell Commun Signal       Date:  2019-01-25       Impact factor: 5.712

10.  Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.

Authors:  Fatma Ibrahim Dwedar; Reham Said Shams-Eldin; Salwa Nayer Mohamed; Ayman Farouk Mohammed; Salwa Hamdi Gomaa
Journal:  J Clin Lab Anal       Date:  2021-07-15       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.